Aortic Valve Disease
Conditions
Brief summary
Since 2009, positive experiences with right anterior minithoracotomy as an approach to aortic valve replacement are extensively practiced in our institution. The primary disease process for which patients are referred remains aortic stenosis. But more and more, we met older patients with both aortic stenosis and other cardiac pathology (coronary artery disease, other valvulopathy...). Even if minimally invasive valve surgery has been demonstrated to significantly improve postoperative course (reduced blood transfusion, pain, hospital lengths of stay) and to enhance postoperative recovery, when compared with a median sternotomy, it is however important to have medical data and statistics in order to better understand the factors influencing morbi-mortality and thereby to continue this improvement.
Interventions
Aortic valve replacement with or without associated cardiac surgery (coronary bypass, mitral valve surgery,...)
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients \> 18 y-o who underwent aortic valve replacement
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 30 days mortality incidence rates | 30 days | Mortality from aortic valve replacement to 30 days post-surgery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 30 days morbidity incidence rates | 30 days | Morbidity from aortic valve replacement to 30 days post-surgery (major adverse cardiac events) |
| Long-term morbimortality incidence rates | 10 years | Morbimortality from aortic valve replacement up to 10 years post-surgery |
Countries
France